Long-term accumulation of amyloid-β, β-secretase, presenilin-1, and caspase-3 in damaged axons following brain trauma

American Journal of Pathology

Volumn 165, Issue 2, 2004, Pages 357-371

  Chen, Xiao Han ^a   Siman, Robert ^a   Iwata, Akira ^a   Meaney, David F ^a   Trojanowski, John Q ^a   Smith, Douglas H ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; CASPASE; CASPASE 3; PRESENILIN 1;

ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; BRAIN INJURY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LOCALIZATION; IMMUNOHISTOCHEMISTRY; NERVE FIBER; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; WESTERN BLOTTING; WHITE MATTER;

EID: 3242770404     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63303-2     Document Type: Article

References (80)

1. Rasmusson DX, Brandt J, Martin DB: Head injury as a risk factor in Alzheimer's disease. Brain Inj 1995, 9:213-219
2. Schofield PW, Tang M, Marder K: Alzheimer's disease after remote head injury: an incidence study. J Neurol Neurosurg Psychiatry 1997, 62:119-124
3. Nemetz PN, Leibso C, Naessens JM: Traumatic brain injury and time to onset of Alzheimer's disease: a population-based study. Am J Epidemiol 1999, 149:32-40
4. Plassman BL, Havtik RJ, Steffens DC, Helms MJ, Newman TN, Drosdick D, Phillips BA, Gau BA, Welsh-Bohmer KA, Burke JR, Guralink JM, Breitner JC: Documented head injury in early adulthood and risk of Alzheimer's disease dementias. Neurology 2000, 8:1158-1166
5. Lye TC, Shores EA: Traumatic brain injury as a risk factor for Alzheimer's disease: a review. Neuropsychol Rev 2000, 10:115-129
6. Jellinger KA, Paulus W, Wrocklage C, Litvan I: Effects of closed traumatic brain injury and genetic factors on the development of Alzheimer's disease. Eur J Neurol 2001, 8:707-710
7. Roberts GW, Gentleman SM, Lynch A, Graham DI: β A4 amyloid protein deposition in brain after head trauma. Lancet 1991, 338:1422-1423
8. Graham DI, Gentleman SM, Lynch A, Roberts GW: Distribution of β-amyloid protein in the brain following severe head injury. Neuropathol Appl Neurobiol 1995, 21:27-34
9. De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W, Von Figura K, Van Leuven F: Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 1998, 391:387-390
10. Selkoe DJ, Wolfe MS: In search of γ-secretase: presenilin at the cutting edge. Proc Natl Acad Sci USA 2000, 97:5690-5692
11. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M: β-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999, 22:735-741
12. Nunan J, Small DH: Regulation of APP cleavage by α-, β-, and γ-secretases. FEBS Lett 2000, 483:6-10
13. Smith DH, Chen XH, Nonaka M, Trojanowski JQ, Lee VM, Saatman KE, Leoni MJ, Xu BN, Wolf JA, Meaney DF: Accumulation of amyloid beta and tau and the formation of neurofilament inclusions following diffuse brain injury in the pig. J Neuropathol Exp Neurol 1999, 58:982-992
14. Smith DH, Chen XH, Iwata A, Graham DI: Amyloid-β accumulation in axons after traumatic brain injury in humans. J Neurosurg 2003, 98:1072-1077
15. Kamal A, Almenar-Queralt A, LeBlanc JF, Roberts EA, Goldstein LS: Kinesin-mediated axonal transport of a membrane compartment containing β-secretase and presenilin-1 requires APP. Nature 2001, 414:643-648
16. Kamal A, Stokin GB, Yang Z, Xia CH, Goldstein LS: Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron 2000, 28:449-459
17. Esler WP, Wolfe MS: A portrait of Alzheimer secretases: new features and familiar faces. Science 2001, 293:1449-1454
18. Pierce JE, Trojanowski JQ, Graham DI, Smith DH, McIntosh TK: Immunohistochemical characterization of alterations in the distribution of amyloid precursor proteins and β-amyloid peptide after experimental brain injury in the rat. J Neurosci 1996, 16:1083-1090
19. Smith DH, Chen XH, Pierce JE, Wolf JA, Trojanowski JQ, Graham DI, McIntosh TK: Progressive atrophy and neuron death for one year following brain trauma in the rat. J Neurotrauma 1997A, 14:715-727
20. Smith DH, Chen XH, Xu BN, McIntosh TK, Gennarelli TA, Meaney DF: Characterization of diffuse axonal pathology and selective hippocampal damage following inertial brain trauma in the pig. J Neuropathol Exp Neurol 1997B, 56:822-834
21. Iwata A, Chen XH, McIntosh TK, Browne KD, Smith DH: Long-term accumulation of amyloid-β in axons following brain trauma without persistent up-regulation of amyloid precursor protein genes. J Neuropathol Exp Neurol 2002, 61:1056-1068
22. Meaney DF, Bean N, Shreiber D, Miller R, Smith DH, Ross DT, Gennarelli TA: Biomechanical analysis of experimental diffuse axonal injury. J Neurotrauma 1995, 4:689-694
23. Felix B, Léger ME, Albe-Fessard D, Marcilloux JC, Rampin O, Laplace JP, Duclos A, Fort F, Gougis S, Costa M, Duclos N: Stereotaxic atlas of the pig brain. Brain Res Bull 1999, 49:1-138
24. Chen XH, Meaney DF, Xu BN, Nonaka M, McIntosh TK, Wolf JA, Saatman KE, Smith DH: Evolution of neurofilament subtype accumulation in axons following diffuse brain injury in the pig. J Neuropathol Exp Neurol 1999, 58:588-596
25. Povlishock JT, Becker DP: Fate of reactive axonal swellings induced by head injury. Lab Invest 1985, 52:540-552
26. Adams JH, Doyle D, Ford I, Gennarelli TA, Graham DI, McLellan DR: Diffuse axonal injury in head injury: definition, diagnosis, and grading. Histopathology 1989, 15:49-59
27. Adams JH, Graham DI, Gennarelli TA, Maxwell WL: Diffuse axonal injury in non-missile head injury. J Neurol Neurosurg Psychiatry 1991, 54:481-483
28. Smith DH, Meaney DF: Axonal damage in traumatic brain injury. Neuroscientist 2000, 6:483-495
29. Nonaka M, Chen XH, Pierce JE, Leoni MJ, McIntosh TK, Wolf JA, Smith DH: Prolonged activation of NF-κB following traumatic brain injury in rats. J Neurotrauma 1999, 16:1023-1034
30. Higuchi M, Lee VM, Trojanowski JQ: Tau and axonopathy in neurodegenerative disorders. Neuromolecular Med 2002, 2:131-150
31. Morfini G, Pigino G, Beffert U, Busciglio J, Brady ST: Fast axonal transport misregulation and Alzheimer's disease. NeuroMolecular Med 2002, 2:89-100
32. Raby CA, Morganti-Kossmann MC, Kossmann T, Stahel PF, Watson MD, Evans LM, Mehta PD, Spiegel K, Kuo YM, Roher AE, Emmerling MR: Traumatic brain injury increases β-amyloid peptide 1-42 in cerebrospinal fluid. J Neurochem 1998, 7:2505-2509
33. Emmerling MR, Morganti-Kossmann MC, Kossmann T, Stahel PF, Watson MD, Evans LM, Mehta PD, Spiegel K, Kuo YM, Roher AE, Raby CA: Traumatic brain injury elevates the Alzheimer's amyloid peptide A β 42 in human CSF: a possible role for nerve cell injury. Ann NY Acad Sci 2000, 903:118-122
34. Bramlett HM, Kraydieh S, Green EJ, Dietrich WD: Temporal and regional patterns of axonal damage following traumatic brain injury: a β-amyloid precursor protein immunocytochemical study in rats. J Neuropathol Exp Neurol 1997, 56:1132-1141
35. Lewen A, Li GL, Nilsson P, Olsson Y, Hillered L: Traumatic brain injury in rat produces changes of β-amyloid precursor protein immunoreactivity. Neuroreport 1995, 26:357-360
36. Gentleman SM, Nash MJ, Sweeting CJ, Graham DI, Roberts GW: β-amyloid precursor protein (β APP) as a marker for axonal injury after head injury. Neurosci Lett 1993, 160:139-144
37. McKenzie KJ, McLellan DR, Gentleman SM, Maxwell WL, Gennarelli TA, Graham DI: Is β-APP a marker of axonal damage in short-surviving head injury? Acta Neuropathol 1996, 92:608-613
38. Lambri M, Djurovic V, Kibble M, Cairns N, AI-Sarraj S: Specificity and sensitivity of βAPP in head injury. Clin Neuropathol 2001, 20:263-271
39. Gorrie C, Oakes S, Duflou J, Blumbergs P, Waite PM: Axonal injury in children after motor vehicle crashes: extent, distribution, and size of axonal swellings using β-APP immunohistochemistry. J Neurotrauma 2002, 19:1171-1182
40. Sherriff FE, Bridges LR, Sivaloganathan S: Early detection of axonal injury after human head trauma using immunocytochemistry for β-amyloid precursor protein. Acta Neuropathol (Berl) 1994, 87:55-62
41. Stone JR, Okonkwo DO, Singleton RH, Mutlu LK, Helm GA, Povlishock JT: Caspase-3-mediated cleavage of amyloid precursor protein and formation of amyloid β peptide in traumatic axonal injury. J Neurotrauma 2002, 19:601-614
42. Weidemann A, Paliga K, Durrwang U, Reinhard FB, Schuckert O, Evin G, Masters CL: Proteolytic processing of the Alzheimer's disease amyloid precursor protein within its cytoplasmic domain by caspase-like proteases. J Biol Chem 1999, 26:5823-5829
43. Gervais FG, Xu D, Robertson GS, Vaillancourt JP, Zhu Y, Huang J, LeBlanc A, Smith D, Rigby M, Shearman MS, Clarke EE, Zheng H, Van Der Ploeg LH, Ruffolo SC, Thornberry NA, Xanthoudakis S, Zamboni RJ, Roy S, Nicholson DW: Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-β precursor protein and amyloidogenic A β peptide formation. Cell 1999, 97:395-406
44. Nishimura I, Uetsuki T, Kuwako K, Hara T, Kawakami T, Aimoto S, Yoshikawa K: Cell death induced by a caspase-cleaved transmembrane fragment of the Alzheimer amyloid precursor protein. Cell Death Differ 2002, 9:199-208
45. Soriano S, Lu DC, Chandra S, Pietrzik CU, Koo EH: The amyloidogenic pathway of amyloid precursor protein (APP) is independent of its cleavage by caspases. J Biol Chem 2001, 276:29045-29050
46. Galvan V, Chen S, Lu D, Logvinova A, Goldsmith P, Koo EH, Bredesen DE: Caspase cleavage of members of the amyloid precursor family of proteins. J Neurochem 2002, 82:283-294
47. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller-Hill B: The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987, 325:733-736
48. Ponte P, Gonzalez-DeWhitt P, Schilling J, Miller J, Hsu D, Greenberg B, Davis K, Wallace W, Lieberburg I, Fuller F: A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature 1988, 11:525-527
49. Selkoe DJ: Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu Rev Cell Biol 1994, 10:373-403
50. Hilbich C, Monning U, Grund C, Masters CL, Beyreuther K: Amyloid-like properties of peptides flanking the epitope of amyloid precursor protein-specific monoclonal antibody 22C11. J Biol Chem 1993, 15:26571-26577
51. Barnes NY, Li L, Yoshikawa K, Schwartz LM, Oppenheim RW, Milligan CE: Increased production of amyloid precursor protein provides a substrate for caspase-3 in dying motoneurons. J Neurosci 1998, 1:5869-5880
52. Solomon B, Koppel R, Hanan E, Katzav T: Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer β-amyloid peptide. Proc Natl Acad Sci USA 1996, 9:452-455
53. Matsunaga Y, Saito N, Fujii A, Yokotani J, Takakura T, Nishimura T, Esaki H, Yamada T: A pH-dependent conformational transition of Aβ peptide and physicochemical properties of the conformers in the glial cell. Biochem J 2002, 1:547-556
54. Hyman BT, Tanzi RE, Marzloff K, Barbour R, Schenk D: Kunitz protease inhibitor-containing amyloid β protein precursor immunoreactivity in Alzheimer's disease. J Neuropathol Exp Neurol 1992, 51:76-83
55. Frenkel D, Balass M, Solomon B: N-terminal EFRH sequence of Alzheimer's β-amyloid peptide represents the epitope of its antiaggregating antibodies. J Neuroimmunol 1998, 1:85-90
56. Miguel-Hidalgo JJ, Cacabelos R: β-amyloid (1-40)-induced neurodegeneration in the rat hippocampal neurons of the CA1 subfield. Acta Neuropathol (Berl) 1998, 95:455-465
57. Jung SS, Gauthier S, Cashman NR: β-amyloid precursor protein is detectable on monocytes and is increased in Alzheimer's disease. Neurobiol Aging 1999, 20:249-257
58. Arai T, Akiyama H, Ikeda K, Kondo H, Mori H: Immunohistochemical localization of amyloid β-protein with amino-terminal aspartate in the cerebral cortex of patients with Alzheimer's disease. Brain Res 1999, 27:202-206
59. DeMattos RB, Bales KR, Cummins DJ, Dodart JC, Paul SM, Holtzman DM: Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2001, 17:8850-8855
60. Horsburgh K, Cole GM, Yang F, Savage MJ, Greenberg BD, Gentleman SM, Graham DI, Nicoll JA: β-amyloid (AP) 42(43), aβ42, aβ40, and apoE immunostaining of plaques in fatal head injury. Neuropathol Appl Neurobiol 2000, 26:124-132
61. Savage MJ, Kawooya JK, Pinsker LP, Emmons T, Mistretta S, Siman R, Greenberg BD: elevated Aβ levels in Alzheimer's disease brain is associated with selective accumulation of Aβ42 in parenchymal amyloid plaques and both Aβ40 and Aβ42 in cerebrovascular deposits. Amyloid: Int J Exp Clin Invest 1995, 2:234-240
62. Hwang DY, Chae KR, Kang TS, Hwang JH, Lim CH, Kang HK, Goo JS, Lee MR, Lim HJ, Min SH, Cho JY, Hong JT, Song CW, Paik SG, Cho JS, Kim YK: Alterations in behavior, amyloid β-42, caspase-3, and Cox-2 in mutant PS2 transgenic mouse model of Alzheimer's disease. EMBO J 2002, 16:805-813
63. Yang F, Mak K, Vinters HV, Frautschy SA, Cole GM: Monoclonal antibody to the C-terminus of β-amyloid. Neuroreport 1994, 27:2117-2120
64. Murphy GM Jr., Forno LS, Higgins L, Scardina JM, Eng LF, Cordell B: Development of a monoclonal antibody specific for the COOH-terminal of β-amyloid 1-42 and its immunohistochemical reactivity in Alzheimer's disease and related disorders. Am J Pathol 1994, 144:1082-1088
65. Pierce JE, Smith DH, Trojanowski JQ, McIntosh TK: Enduring cognitive, neurobehavioral, and histopathological changes persist for up to one year following severe experimental brain injury in rats. Neuroscience 1998, 87:359-369
66. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y: Visualization of A β 42(43) and A β 40 in senile plaques with end-specific A β monoclonals: evidence that an initially deposited species is A β 42(43). Neuron 1994, 13:45-53
67. Tamaoka A, Sawamura N, Odaka A, Suzuki N, Mizusawa H, Shoji S, Mori H: Amyloid β protein 1-42/43 (A β 1-42/43) in cerebellar diffuse plaques: enzyme-linked immunosorbent assay and immunocytochemical study. Brain Res 1995, 8:151-156
68. Howland DS, Savage MJ, Huntress FA, Wallace RE, Schwartz DA, Loh T, Melloni Jr RH, DeGennaro LJ, Greenberg BD, Siman R: Mutant and native human β-amyloid precursor proteins in transgenic mouse brain. Neurobiol Aging 1995, 16:685-699
69. Reaume AG, Howland DS, Trusko SP, Savage MJ, Lang DM, Greenberg BD, Siman R, Scott RW: Enhanced amyloidogenic processing of the β-amyloid precursor protein in gene-targeted mice bearing the Swedish familial Alzheimer's disease mutations and a "humanized" Aβ sequence. J Biol Chem 1996, 20:23380-23388
70. Shaw G, Osborn M, Weber K: Reactivity of a panel of neurofilament antibodies on phosphorylated and dephosphorylated neurofilaments. Eur J Cell Biol 1986, 42:1-9
71. Harris J, Ayyub C, Shaw G: A molecular dissection of the carboxyterminal tails of the major neurofilament subunits NF-M and NF-H. J Neurosci Res 1991, 30:47-62
72. Fernandes-Alnemri T, Armstrong RC, Krebs J, Srinivasula SM, Wang L, Bullrich F, Fritz LC, Trapani JA, Tomaselli KJ, Litwack G, Alnemri ES: In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci USA 1996, 23:7464-7469
73. Casciola-Rosen L, Nicholson DW, Chong T, Rowan KR, Thornberry NA, Miller DK, Rosen A: Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med 1996, 1:1957-1964
74. Hussain I, Powell D, Howlett DR, Tew DG, Meek TD, Chapman C, Gloger IS, Murphy KE, Southan CD, Ryan DM, Smith TS, Simmons DL, Walsh FS, Dingwall C, Christie G: Identification of a novel aspartic protease (Asp 2) as β-secretase. Mol Cell Neurosci 1999, 14:419-427
75. Li J, Xu M, Zhou H, Ma J, Potter H: Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell 1997, 5:917-927
76. Wen PH, Friedrich Jr VL, Shioi J, Robakis NK, Elder GA: Presenilin-1 is expressed in neural progenitor cells in the hippocampus of adult mice. Neurosci Lett 2002, 25:53-56
77. Morfini G, Szebenyi G, Richards B, Brady ST: Regulation of kinesin: implications for neuronal development. Dev Neurosci 2001, 23:364-376
78. Vancoillie G, Lambert J, Mulder A, Koerten HK, Mommaas AM, Van Oostveldt P, Naeyaert JM: Kinesin and kinectin can associate with the melanosomal surface and form a link with microtubules in normal human melanocytes. J Invest Dermatol 2000, 114:421-429
79. Kosik KS, Orecchio LD, Schnapp B, Inouye H, Neve RL: The primary structure and analysis of the squid kinesin heavy chain. J Biol Chem 1990, 25:3278-3283
80. Soares HD, Hicks RR, Smith D, McIntosh TK: Inflammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury. J Neurosci 1995, 15:8223-8233